BMY Related Upgrades
-
Citi Upgrades Bristol-Myers Squibb Co. (BMY) to Buy
-
UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
-
Atlantic Equities Upgrades Bristol-Myers Squibb Co. (BMY) to Neutral
-
Goldman Sachs Upgrades Bristol-Myers Squibb Co. (BMY) to Conviction Buy
-
BofA/Merrill Lynch Upgrades Bristol-Myers Squibb Co. (BMY) to Buy
-
UPDATE: Onyx Pharma (ONXX) Shares Rise as Leerink Swann Upgrades to Outperform
-
Credit Agricole Upgrades Bristol-Myers Squibb (BMY) Two Notches to Outperform
-
Goldman Sachs Upgrades Bristol-Myers Squibb Co. (BMY) to Buy
-
Jefferies Upgrades Bristol-Myers Squibb Co. (BMY) to Buy, "Prime Target for Acquisition"
-
Atlantic Equities Upgrades Bristol-Myers Squibb Co. (BMY) to Neutral
-
Morgan Stanley Upgrades Bristol-Myers Squibb Co. (BMY) to Overweight
-
Goldman Sachs Upgrades Johnson & Johnson (JNJ) to Buy; Best New Product Story In Pharma
-
Cowen Upgrades Bristol-Myers (BMY) to Outperform, Downgrades Merck (MRK) to Neutral
-
Wells Fargo on Large Cap Pharma: Upgrading To Overweight
-
Jefferies Upgrades Bristol-Myers (BMY) to Buy
-
Citi Upgrades Bristol-Myers Squibb (BMY) to Buy; Solid Pipeline Progress
-
Citi & Leerink Swann Upgrade Bristol-Myers (BMY) to Buy/Outperform
-
Bristol Myers (BMY) Breaks Out of a Rut; Can It Last?
-
Hapoalim Securities Upgrades Bristol-Myers Squibb (BMY) to Hold; The Darling of ASCO
-
Goldman Sachs Upgrades Bristol Myers (BMY) to Buy
-
Morgan Stanley Upgrades Bristol-Myers (BMY) to Overweight, Raises Target to $28
-
Miller Tabak Upgrades Major Drug Manufacturers BMY, MRK & NVS
-
Citi Upgrades Bristol-Myers Squibb (BMY) to Buy
-
Matrix Lighthouse Rating Changes 10/16
-
Merrill Lynch Upgrades Bristol-Myers Squibb (BMY) to Buy
-
Matrix USA Rating Changes 8/1:
-
Matrix USA Rating Changes 7/9
-
Bernstein Upgrades Bristol-Myers (BMY) to Outperform
-
Matrix USA Rating Changes 5/12
-
Matrix USA Rating Changes 3/4
-
Cowen Upgrades Bristol-Myers Squibb (BMY) to Outperform
-
Argus Upgrades Bristol-Myers Squibb (BMY) to Buy
-
Cowen Upgrades Bristol-Myers (BMY) to Neutral
-
Bear Stearns upgrades Bristol-Myers (BMY) to Outperform
-
Citigroup Upgrades Bristol-Myers Squibb Co (BMY) to Buy
-
Deutsche Bank upgrades Bristol-Myers Squibb (BMY) to Buy
-
UBS upgrades Bristol Myers (BMY) to Buy
-
Prudential Securities Upgrades Bristol-Myers Squibb (BMY) to Overweight
-
A Number of Brokers Upgrade Bristol-Myers Squibb (NYSE: BMY)
-
Friedman Billings upgrades BMY to Outperform
Back to BMY Stock Lookup
